Skip to main content
Premium Trial:

Request an Annual Quote

Glencoe Software, Aridhia Join Forces to Develop Personalized Medicine Software

Premium

This week, Glencoe Software and Aridhia Informatics announced that they will combine their respective capabilities to develop personalized medicine software for the life science and clinical data markets.

Specifically, Aridhia will provide capabilities around accessing, storing, and analyzing healthcare information while Glencoe will provide expertise in managing, sharing, and publishing scientific datasets, the companies said in a statement.

Andrew Morris, co-founder of Aridhia and director of the University of Dundee's medical research institute, said that the partners have "complementary strengths" that would prove useful for providing "the clinical and scientific information required for personalized, targeted drugs and treatments."

Under the terms of the agreement, Aridhia will make an undisclosed investment in Glencoe that is expected to increase the latter's footprint, the partners said, but did not provide additional details.

Founded in 2008, Aridhia is a health informatics company that was formed as a joint venture between the Scottish National Health Service, the University of Dundee, and Sumerian, an information technology and services firm. It offers services for patient tracking, clinical dashboards, and infection control among other areas.

Glencoe, another Dundee spinout, was founded in 2005 to commercialize open source software developed by the Open Microscopy Environment Consortium. The company provides commercial access to and customization of OME resources including the OMERO platform and the Bio-Formats package.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.